> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Clears DT MedTech’s Ankle Replacement System
- URL: https://www.fdaweb.com/fda-clears-dt-medtechs-ankle-replacement-system/
- Published: 2017-11-09T12:00:00.000Z
- Updated: 2026-09-14T23:01:03.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5140103

FDA has cleared a DT MedTech 510(k) for its Hintermann Series H2 Total Ankle Replacement System. The semi-constrained, total ankle replacement prosthesis is indicated for use with bone cement to treat ankle arthritis in either primary or revision surgery of ankle joints damaged by systemic arthritis, primary arthritis (*e.g.,* degenerative disease), and secondary arthritis (*e.g.,* traumatic, avascular necrosis). The device is also indicated for patients with a failed total ankle replacement or non-union/mal-union of the ankle arthrodesis, provided that sufficient bone stock is present.